Symptomatic carotid artery stenosis: what is the preferred treatment?

Daniel S Menees1, Eric R Bates

  • 1Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Insights

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are effective treatments for carotid artery stenosis, a common cause of stroke. Both procedures offer benefits, with the choice depending on individual patient factors and surgical risk.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Cardiology

Background:

  • Stroke is a leading cause of death and disability, with carotid artery disease accounting for 15-20% of cases.
  • Carotid endarterectomy (CEA) is a proven treatment for symptomatic carotid stenosis, reducing stroke risk in select patients.
  • Carotid artery stenting (CAS) has emerged as an alternative, particularly for high-risk surgical candidates.

Purpose of the Study:

  • To compare the efficacy and safety of CEA and CAS for treating carotid artery stenosis.
  • To identify patient characteristics that may favor one procedure over the other.
  • To review the current evidence on revascularization strategies for carotid artery disease.

Main Methods:

  • Systematic review and meta-analysis of existing studies comparing CEA and CAS.
  • Analysis of patient outcomes including stroke, death, and myocardial infarction.
  • Evaluation of factors influencing treatment choice, such as patient age, stenosis severity, and anatomy.

Main Results:

  • Both CEA and CAS reduce the risk of stroke and death in symptomatic patients with significant carotid stenosis.
  • CAS may have a higher risk of nondisabling stroke, but this is mitigated by embolic protection devices.
  • CAS is associated with a lower risk of myocardial infarction compared to CEA, with no difference in disabling stroke or death.
  • Operator experience and patient-specific factors influence outcomes, with CEA potentially favored in older patients with complex anatomy and CAS in younger patients or those with restenosis.

Conclusions:

  • CEA and CAS are complementary revascularization strategies for carotid artery stenosis.
  • The optimal treatment choice depends on a comprehensive assessment of individual patient risk factors, anatomy, and procedural considerations.
  • Optimal medical therapy remains crucial for all patients to manage secondary risk factors and prevent future cardiovascular events.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...